|
⚲
|
| Keyboard |
| Cordova Ashley
✚
|
|
|---|---|
| CIK # | 0001822014 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001822014] | |
| 4 | [0001822014] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Cordova Ashley | |
| NovoCure Ltd |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-04 | Tax withheld | 17,638 | $13.30 | 234,585 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-02 | Tax withheld | 2,410 | $13.67 | 32,945 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-03-02 | Tax withheld | 7,228 | $13.67 | 98,807 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-02-28 | Grant | 23,818 | $0.00 | |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2026-02-27 | Tax withheld | 11,541 | $13.75 | 158,689 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-06-30 | Grant | 833 | $15.13 | 12,603 |
|
NovoCure Ltd NVCR
Stock Options (Right to buy) · derivative
|
2025-03-04 | Grant | 224,123 | $18.19 | 4,076,797 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-03-04 | Grant | 151,181 | $18.19 | 2,749,982 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-03-03 | Sell | 2,053 | $18.54 | 38,063 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-02-28 | Sell | 2,341 | $18.28 | 42,793 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-02-27 | Sell | 9,345 | $19.92 | 186,152 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2025-02-27 | Sell | 1,808 | $20.55 | 37,154 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2024-12-31 | Grant | 373 | $14.75 | 5,502 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2024-08-02 | Sell | 688 | $20.14 | 13,856 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2024-06-28 | Grant | 1,286 | $12.24 | 15,741 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2024-02-27 | Grant | 102,249 | $16.30 | 1,666,659 |
|
NovoCure Ltd NVCR
Stock Options (Right to buy) · derivative
|
2024-02-27 | Grant | 156,348 | $16.30 | 2,548,472 |
|
NovoCure Ltd NVCR
Ordinary Shares
|
2023-11-02 | Option exercise | 175 | $11.46 | 2,006 |
|
NovoCure Ltd NVCR
Stock Option (Right to Buy) · derivative
|
2023-11-02 | Option exercise | 175 | $0.00 | |
|
NovoCure Ltd NVCR
Stock Option (Right to Buy) · derivative
|
2023-10-31 | Option exercise | 7,561 | $0.00 | |
| showing 20 of 84 most recent transactions | |||||